Pharmacist's Letter Canada | Convenient Monthly Updates + CE

Current Issue

April 2026 Issue

Know How Bempedoic Acid Stacks Up to Other Non-Statins

You’ll hear buzz about bempedoic acid (Nilemdo), a new oral non-statin cholesterol med...

Resources

Chart: Non-Statin Lipid-Lowering Agents

Antimicrobial Stewardship: Separate Fact From Fiction

Antimicrobial resistance continues to be a public health threat...

Be Ready for Questions About GLP-1 Use in Breastfeeding

We’re getting questions about the safety of GLP-1 agonists (semaglutide, etc) while breastfeeding...

Expect a Limited Role for Zuranolone in Postpartum Depression

Zuranolone (Zurzuvae) will be the first med approved for treating postpartum depression...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Diabetes Medication Review

CE-IN-THE-LETTER: Pharmacist's Letter Canada April 2026

LIVE CE: Pharmacy Essential Updates April 2026

PODCAST CE: Rumor vs Truth - Artificial Intelligence

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Inhalation Medications for Asthma (Canada)

Stepwise Treatment of Asthma j12 Years and Older

Group Purchases & Pricing

Pharmacist’s Letter Canada is eligible for bulk discounts. Easily manage staff access and customize CE & training assignments. Bundle with other products for significant savings. Request information